Online Program Home
  My Program
CC = Baltimore Convention Center,    H = Hilton Baltimore
* = applied session       ! = JSM meeting theme

Activity Details

393 * ! Tue, 8/1/2017, 2:00 PM - 3:50 PM CC-304
Using Patient-Reported Outcomes to Capture Symptomatic Adverse Events in Cancer Clinical Trials: Challenges and Opportunities — Topic Contributed Papers
Health Policy Statistics Section
Organizer(s): Joseph Cappelleri, Pfizer Inc
Chair(s): Joseph Cappelleri, Pfizer Inc
2:05 PM Patient-Reporting of Symptomatic Toxicities of Cancer Treatment: Current Progress and Emerging Challenges Sandra Anne Mitchell, National Cancer Institute
2:25 PM PRO-CTCAE Implementation in Oncology Clinical Trials: An Industry Perspective Paivi Miskala, Pfizer Inc
2:45 PM PRO-CTCAE in Oncology Clinical Trials: a U.S. Regulatory Perspective Paul Kluetz, U.S. Food and Drug Administration
3:05 PM Statistical Methods to Analyze PRO-CTCAE Data in Oncology Clinical Trials Amylou Dueck, Mayo Clinic
3:25 PM Discussant: Rajeshwari Sridhara, U.S. Food and Drug Administration
3:45 PM Floor Discussion
Copyright © American Statistical Association